Share
1,255 Posts.
lightbulb Created with Sketch. 12
clock Created with Sketch. 18/12/16
16:02
Share
Originally posted by craft
↑
I don’t think it’s really necessary to consider his whole tax position.th July 114,968 performance rights vested and were converted into ordinary shares. He paid Nil for these but for tax purposes they would have had a deemed value of current market value. (Might have been 5 day VWAP) but let’s just go with market close on the day of $31.47. Therefore he would has deemed assessable income of 114,968 x $31.47 = $3,618,043 which would be taxed at his marginal tax rate – presumably 45% plus 2% levy plus Medicare = 49%Sad thing is the internally funded growth of the business to date could have been a great legacy to current board and management and still could be if they can quickly pass the baton onto the right people for the next stage of the SRX story.
Expand
It would be nice to see a breakdown of monthly dose sales data for the year, with indication (mCRC, HCC, NET, other). When did sales break down in relationship to GW's share selldown? Is this still trending down or is there any sign of recovery? And can this really be blamed on Lonsurf? Is it accurate to claim that they have only penetrated 2% of the salvage market and if so doesn't the slow down indicate a massive fail by management? Didn't they spend a crapload on marketing post SIRFLOX, apparently to no benefit? If they are not on top of monthly sales data, why not? Really hoping the trials data is positive to salvage the co. GW on the way out but lots of answers still needed
(20min delay)